Durvalumab vs Exenatide

## Durvalumab vs Exenatide: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Exenatide**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Exenatide**: Synthetic exendin-4 GLP-1 receptor agonist enhancing glucose-dependent insulin secretion.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Exenatide — 2.4 hours.

## Chemical Properties

**Type**: Durvalumab — Antibody; Exenatide — Protein.